Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,260 across all filing types
Latest filing 2025-04-04 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. It informs about the receipt of regulatory permission from the Central Drugs Standard Control Organization for an additional indication of a pharmaceutical product. The content is an intimation or announcement of a material event related to the company, not a financial report, earnings release, or detailed management discussion. The document length is short (1649 characters) and is a notification rather than a report. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-04-04 English
Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. It informs about the receipt of regulatory permission from the Central Drugs Standard Control Organization for an additional indication of a pharmaceutical product. The content is an intimation or announcement of a material event or regulatory update rather than a financial report, management change, or detailed presentation. The document length is short (1649 characters) and does not contain financial data or detailed analysis. It fits the profile of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-04-04 English
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges (BSE and NSE) informing them about a scheduled interaction with analysts and investors. It references Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of an upcoming investor meeting, not a financial report, earnings release, or detailed presentation. The document length is only 1312 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2025-04-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges (BSE and NSE) informing them about a scheduled interaction with analysts and investors. It references Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of an upcoming investor meeting, not a financial report or detailed presentation. The document length is only 1312 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and disclosures that do not fit other specific categories.
2025-04-04 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the declaration of voting results of a Postal Ballot along with the Scrutinizer's Report. It references a previous Postal Ballot Notice and states that the resolution was passed by the members with the requisite majority. The document includes voting results and the Scrutinizer's Report and mentions compliance with SEBI regulations. The content is focused on announcing the official results of shareholder voting, not the full meeting materials or the report itself. The document length is short (1918 characters), and it serves as an official announcement of voting results rather than a detailed report or presentation. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-03-28 English
Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.
Regulatory Filings
2025-03-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.